Indian pharmaceutical stocks fell sharply on July 22 after US President Donald Trump announced plans to impose steep tariffs ...

German family-owned drugmaker Grünenthal has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a ...

French health company Opella revealed it has inaugurated a new state-of-the-art production line for Enterogermina in Mexico ...

US immunology specialist Celldex yesterday reported mixed top-line results from the company’s Phase II study of barzolvolimab ...

US clinical-stage biopharma Jupiter Neurosciences has signed a definitive licensing agreement with Canadian biotech PharmAla ...

Sanofi (Euronext: SAN; Nasdaq: SNY) has announced changes to its executive committee, as the French pharma major streamlines senior leadership under chief executive Belén Garijo. The revised structure ...

Lonza and Engitix, a UK-based ECM-based drug discovery and development firm, today announced a licensing agreement to advance ...

Germany’s Allogenetics today announced the appointment of Dr Jeroen Rovers as chief medical officer (CMO). The company noted ...

Kolon TissueGene has reported that the first of two pivotal US Phase III trials of TissueGene-C (TG-C), its experimental cell ...

US biotech Dyne Therapeutics has moved closer to a possible first approval after the US Food and Drug Administration accepted ...

A Waltham, Massachusetts-based clinical-stage biotechnology company targeting migraine prevention through the PACAP pathway and a potentially first-in-class PACAP/CGRP bispecific antibody designed to ...

US biotech Regenxbio on Friday announced the pricing of an underwritten public offering of 10,003,889 shares of its common ...